Iris Moll
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Immune Cell Function and Interaction 2
-
- Developmental Biology and Gene Regulation 3
- RNA regulation and disease 2
- Co-authors
- Antje Sucker (10 shared papers)Dirk Schadendorf (10 shared papers)Susanne Horn (2 shared papers)Kari Hemminki (2 shared papers)Eduardo Nagore (2 shared papers)Rajiv Kumar (2 shared papers)Andreas Gast (1 shared paper)P. Sivaramakrishna Rachakonda (1 shared paper)
- Journals
- PLoS ONE (3 papers)EMBO Molecular Medicine (3 papers)Nature Communications (2 papers)Clinical Cancer Research (2 papers)Cardiovascular Research (1 paper)
- Partner nations
- GermanySpainUnited States
In The Last Decade
Iris Moll
35 papers receiving 3.1k citations
Iris Moll's Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 500
- Oncology 908
- Aging 52
- Immunology 557
- Physiology 538
Countries citing papers authored by Iris Moll
This map shows the geographic impact of Iris Moll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Moll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Moll more than expected).
Fields of papers citing papers by Iris Moll
This network shows the impact of papers produced by Iris Moll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Moll. The network helps show where Iris Moll may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Moll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TERT Promoter Mutations in Familial and Sporadic Melanoma Hit paper breakdown → | 2013 | 1476 |
| 2 | 2017 | 263 | |
| 3 | 2009 | 161 | |
| 4 | 2014 | 148 | |
| 5 | 2018 | 122 | |
| 6 | 2006 | 102 | |
| 7 | 2008 | 84 | |
| 8 | 2013 | 81 | |
| 9 | 2013 | 76 | |
| 10 | 2015 | 63 | |
| 11 | 2022 | 57 | |
| 12 | 2017 | 53 | |
| 13 | 2011 | 47 | |
| 14 | 2010 | 40 | |
| 15 | 2018 | 33 | |
| 16 | 2023 | 32 | |
| 17 | 2018 | 28 | |
| 18 | 2020 | 24 | |
| 19 | 2020 | 24 | |
| 20 | 2015 | 24 |
About Iris Moll
Iris Moll is a scholar working on Immunology, Molecular Biology, Dermatology, Oncology and Neurology, having authored 36 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (4 papers), Developmental Biology and Gene Regulation (3 papers), Vascular Malformations Diagnosis and Treatment (2 papers), Cancer and Skin Lesions (2 papers), Immune Cell Function and Interaction (2 papers), Cerebrovascular and genetic disorders (2 papers), Cell Adhesion Molecules Research (2 papers) and RNA regulation and disease (2 papers). The work is most often cited by research in Cancer Research (500 citations), Oncology (908 citations), Aging (52 citations), Immunology (557 citations) and Physiology (538 citations). Iris Moll has collaborated with scholars based in Germany, Spain and United States. Frequent co-authors include Antje Sucker, Dirk Schadendorf, Susanne Horn, Kari Hemminki, Eduardo Nagore, Rajiv Kumar, Andreas Gast, P. Sivaramakrishna Rachakonda, Christine Fischer and Adina Figl. Their work appears in journals such as PLoS ONE, EMBO Molecular Medicine, Nature Communications, Clinical Cancer Research and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.